XML 23 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
BAV
Stock Compensation Plan
Pre-spin equity grants expense
Stock Compensation Plan
Series D Convertible Preferred Stock
Common Stock
Common Stock
BAV
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
BAV
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests in Consolidated Entities
Convertible Preferred Stock
Redeemable Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2018           2,392               8,120  
Beginning balance at Dec. 31, 2018 $ 65,901         $ 24     $ 280,159   $ (214,242) $ (498) $ 458 $ 200,847 $ 3,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Equity-based compensation (in shares)           0                  
Equity-based compensation 2,158               2,155   0   3    
Allocated stock-based compensation expense 8,026   $ 2,158                        
Acquisitions (in shares)             60                
Acquisitions   $ 3,755         $ 1     $ 3,754          
Investment in Real Estate Advisory Holdings LLC (in shares)           17                  
Investment in Real Estate Advisory Holdings LLC 1,000               1,000            
Amortization of preferred stock discount (491)                   (491)     $ 491  
Dividends declared - preferred stock (2,791)                   (2,791)        
Dividends undeclared - preferred stock $ 0                            
Deferred compensation plan distribution (in shares) 1         1                  
Deferred compensation plan distribution $ 46                            
Employee advances 249               249            
Contributions from noncontrolling interests 455                       455    
Reallocation of carrying value (356)               (234)       (122)   356
Redemption value adjustment 111                   111       (111)
Distributions to consolidated noncontrolling interests (4)                   0   (4)    
Foreign currency translation adjustment 15                     15     13
Reclassification for realized loss (gain) on available for sale securities 0                            
Net income (loss) 710                   710        
Net income (loss) 547                       (163)   21
Ending balance (in shares) at Mar. 31, 2019           2,470               8,120  
Ending balance at Mar. 31, 2019 70,595         $ 25     287,129   (216,703) (483) 627 $ 201,338 3,810
Beginning balance (in shares) at Dec. 31, 2018           2,392               8,120  
Beginning balance at Dec. 31, 2018 65,901         $ 24     280,159   (214,242) (498) 458 $ 200,847 3,531
Ending balance (in shares) at Dec. 31, 2019           2,203   (2)           19,120  
Ending balance at Dec. 31, 2019 42,024                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common stock 2                            
Accumulated deficit (244,084)                            
Noncontrolling interests in consolidated entities 628                            
Convertible preferred stock         $ 474,060                    
Accumulated other comprehensive income (loss) (216)                            
Redeemable noncontrolling interests 4,131                            
Treasury stock               $ (131)              
Additional paid-in capital 285,825                            
Equity-based compensation (in shares)           257                  
Equity-based compensation 2,190               2,187       3    
Forfeiture of restricted common shares 0             $ (13) 13            
Forfeiture of restricted common shares (in shares)               (1)              
Purchase of treasury stock (5)             $ (5) 0            
Allocated stock-based compensation expense 8,940   $ 2,049 $ 0                      
Shares acquired (in shares)               (1)              
Amortization of preferred stock discount (810)                   (810)     $ 810  
Dividends declared - preferred stock (3,938)                            
Dividends undeclared - preferred stock (3,937)                            
Deferred compensation plan distribution (in shares)           0                  
Deferred compensation plan distribution 2                            
Employee advances 124               124            
Contributions from noncontrolling interests 77                       77    
Reallocation of carrying value (56)               (37)       (19)   56
Redemption value adjustment (322)                   (322)       322
Foreign currency translation adjustment 388                     388     51
Unrealized gain (loss) on available for sale securities (856)                     (856)      
Reclassification for realized loss (gain) on available for sale securities 375                     375      
Net income (loss) (177,640)                   (177,640)        
Net income (loss) (177,800)                       (160)   (440)
Ending balance (in shares) at Mar. 31, 2020           2,460   (4)           19,120  
Ending balance at Mar. 31, 2020 (142,544)         $ 2   $ (149) $ 288,114   $ (430,731) $ (309) $ 529 $ 474,870 $ 4,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common stock 2                            
Accumulated deficit (430,731)                            
Noncontrolling interests in consolidated entities 529                            
Convertible preferred stock         $ 474,870                    
Accumulated other comprehensive income (loss) (309)                            
Redeemable noncontrolling interests 4,120                            
Treasury stock (149)                            
Additional paid-in capital $ 288,114